ArticleInternational journal of impotence research2022

Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study.

Pablo Garrido-Abad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.